arbekacin has been researched along with clarithromycin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Higashide, M; Ichimura, S; Kumano, M; Kuroda, M; Ohkawa, S; Ohta, T; Omura, CT | 1 |
| Arai, Y; Fujimoto, Y; Handoh, T; Ihara, H; Kurokawa, K; Miida, T; Misawa, S; Naito, T; Nakamura, A; Ochi, Y; Okabe, T; Shibayama, K; Sumiyoshi, I; Tabe, Y; Takahashi, K; Takei, S; Togo, S; Watanabe, J | 1 |
2 other study(ies) available for arbekacin and clarithromycin
| Article | Year |
|---|---|
Methicillin-resistant Staphylococcus saprophyticus isolates carrying staphylococcal cassette chromosome mec have emerged in urogenital tract infections.
Topics: Bacterial Proteins; Chromosomes, Bacterial; Electrophoresis, Gel, Pulsed-Field; Methicillin Resistance; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Analysis, DNA; Staphylococcal Infections; Staphylococcus; Urinary Tract Infections | 2008 |
The synergetic effect of sitafloxacin-arbekacin combination in the Mycobacterium abscessus species.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Humans; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous | 2023 |